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RetrotransposonRNA interference (RNAi) denotes sequence-speciﬁc mRNA degradation induced by long double-
stranded RNA (dsRNA). RNAi is an ancient eukaryotic defense mechanism against viruses andmobile
elements. In mammals, endogenous RNAi was outstripped during evolution by the current innate
and acquired immunity. The RNAi apparatus, which remains essentially intact, serves mostly the
microRNA pathway, which regulates endogenous gene expression. Remarkably, several recent
publications brought the mammalian endogenous RNAi pathway back into the spotlight. Here, I will
provide an up-to-date review of the mammalian endogenous RNAi pathway with a focus on its
defensive role and overlaps with miRNA and piRNA pathways.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The deﬁning feature of RNA silencing pathways is utilization of
small RNAmolecules (20–30 nucleotides long), which form ribonu-
cleoprotein complexes with proteins from the Argonaute family. In
addition to Argonaute proteins, biogenesis of small RNAs often (but
not always) involves activity of RNase III Dicer. In mammals, there
are three well-deﬁned RNA silencing pathways: RNA interference
(RNAi), microRNA (miRNA) and piRNA pathways (the last being
named after small RNAs bound by Argonaute proteins from a PIWI
subfamily). Molecular mechanisms of RNAi, miRNA and piRNA
pathways have been described in detail elsewhere [1–4] and are
brieﬂy summarized in Fig. 1A. In the following text, I will focus
on the current view of the mammalian RNAi pathway with a par-
ticular emphasis on mechanistical and functional overlaps with
miRNA and piRNA pathways.
2. Endogenous RNAi in mammals – rudimentary but alive
RNAi (Fig. 1A) was originally deﬁned as sequence-speciﬁc
mRNA degradation induced by long double stranded RNA (dsRNA)
[5]. Subsequently, the term RNAi became popular and obtained dif-
ferent contextual connotations such that RNAi is used to denoteleast three entities. First, RNAi is used as a synonym for RNA silenc-
ing (e.g. Wikipedia or [6]), i.e. for functionally and mechanistically
different pathways employing small RNAs loaded on Argonaute
proteins. Second, the term RNAi is used for an experimental gene
regardless, which RNA silencing pathway is actually employed by
the RNAi approach. Third, RNAi is used as a name for an endoge-
nous mechanisms, which is initiated by long dsRNA and results
in sequence-speciﬁc RNA degradation – as coined for the mecha-
nism discovered in Caenorhabditis elegans by Fire and Mello [5].
In the following text, the term RNAi is strictly used for the molec-
ular mechanism, which is triggered by long dsRNA, the other two
connotations of RNAi are distinguished in the text as RNA silencing
and RNAi approach.
In mammals, RNAi was ﬁrst observed in mouse oocytes where
microinjection of long dsRNA induced suppression of gene expres-
sion via sequence-speciﬁc mRNA degradation [7,8]. I would like to
highlight several notable mechanistical aspects of RNAi.
The ﬁrst step of RNAi involves cleavage of long dsRNA into so-
called short-interfering RNAs (siRNAs) by Dicer. Mammals have a
single Dicer gene encoding a 215 kDa multidomain protein
(Fig. 1B). Biochemical and structural studies show that Dicer func-
tions as a molecular ruler binding a dsRNA end and cleaving both
strands of the duplex 21–22 nucleotides from the end (Fig. 1B,
reviewed in detail in [1]). The end is recognized by the piwi/
argonaute/zwille (PAZ domain), which has a high afﬁnity for a pro-
truding two nucleotide 30-end overhang [9–12]. Such overhang is
present either in dsRNA cleaved by Dicer or in miRNA precursors,
where the overhang is produced during nuclear processing of
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Fig. 1. RNAi in mammals (A) mammalian RNA silencing pathways and their essential components. The miRNA pathway (reviewed in [1,2]) is the best understood mammalian
RNA silencing pathway. In somatic cell, miRNAs are the most abundant and functionally dominant small RNA class. During miRNA biogenesis, RNase III Dicer cleaves small
hairpin precursors (pre-miRNAs) and produces 21–23 nt long miRNAs loaded on the RNA-induced silencing complex (RISC). The RNAi pathway (reviewed in [3]) shares
protein components with the miRNA pathway. RNAi employs 22 nt long small interfering RNAs (siRNA) produced by Dicer from long dsRNA. The key component of RISC is
an AGO protein from the Argonaute protein family. Mammals have four AGO proteins (AGO1–4). All AGO proteins bind miRNAs and siRNAs. AGO1, AGO3, and AGO4 induce
translational repression. Only AGO2 is capable of endonucleolytic cleavage of cognate RNAs, which is the hallmark of RNAi. miRNAs loaded on AGO2 can induce
endonucleolytic cleavage upon perfect basepairing with targets. However, a typical miRNA binding is imperfect and results in translational repression. miRNAs function as
gene-speciﬁc inhibitors where miRNA networks provide a combinatorial system of post-transcriptional control of gene expression. The experimental gene knock-down in
mammalian cells relies on short RNAs – typically synthetic siRNAs or expressed miRNA-like molecules. The piRNA pathway (reviewed in [4]) operates in the germline.
Substrates for the piRNA pathway are sense and antisense transcripts from discrete genomic loci (piRNA clusters), which are produced by a complex, Dicer-independent
mechanism (not shown). piRNAs are longer than siRNAs and miRNAs (24–30 nt) and they are loaded onto Argonaute proteins from the PIWI subfamily. In the mouse, there
are three PIWI proteins: MILI, MIWI, and MIWI2, which differ in expression and populations of associated piRNAs but all are essential for spermatogenesis [40–42]. Notably,
murine piRNAs are produced in male and female germ cells but, unlike in the zebraﬁsh [96], piRNAs are essential for development of male germ cells [40–42]. Similarly to
siRNAs, piRNAs can direct endonucleolytic cleavage of cognate RNAs. In addition, they can also direct de novo DNA methylation. (B) Dicer RNase III, the key player in
biogenesis of miRNAs and siRNAs (reviewed in [1,97]). Mammals have a single Dicer gene encoding 215 kDa protein containing several conserved domains, including N-
terminal DEAD-like and helicase superfamily C domains, the piwi/argonaute/zwille (PAZ) domain, two RNase III domains, and the C-terminal double-stranded RNA binding
domain (dsRBD). The PAZ domain binds a 30 protruding overhang in dsRNAs or miRNA precursors. Two RNase III domains form a single processing center producing a short
dsRNA with a 2 nt 30 overhang, where each domain cleaves one strand of the duplex. Thus, Dicer acts as a molecular ruler, measuring the substrate length from the PAZ
domain to RNase III domains. The scheme of Dicer organization is based on previous structural studies [98,99]. (C) Endogenous siRNAs derived from repetitive sequences and
processed pseudogenes occur in mouse oocytes because of a unique Dicer isoform adapted to effective processing of long dsRNAs [52].
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time, long dsRNAs appear in different forms (Fig. 2A), which typi-
cally do not have the optimal overhang. Biochemical studies
showed that Dicer cleaves blunt-end dsRNA (e.g. produced during
viral replication) preferentially from the termini [13,14] while long
single-strand overhangs (e.g. appearing upon transcription of a
locus carrying an inverted repeat) result in less efﬁcient dsRNA
processing [15]. However, an internal RNA duplex cleavage, which
occurs at low frequency [14], would leave behind two fragments
with two nucleotide 30-end overhangs that would represent opti-
mal substrates for further cleavage. These two modes of cleavage
by Dicer could explain distinct proﬁles of 21–23 nt RNA popula-
tions arising from different types of substrates in vivo (Fig. 2B).
In Drosophila, RNAi pathway exists as a genetically, mechanisti-
cally, and functionally distinct pathway utilizing dedicatedproteins including Dicer and Argonaute (reviewed in detail in
[3]). In mammals, once is a long dsRNA encountered by Dicer,
the mammalian RNAi pathway mechanistically essentially merges
with the miRNA pathway. Thus, the key distinction between mam-
malian RNAi and miRNA pathways is the substrate processed by
Dicer and not the silencing effect per se (Fig. 1A). A popular distinc-
tion between miRNA and RNAi pathways, which attributes transla-
tional repression to miRNAs and endonucleolytic cleavage in the
middle of the cognate sequence to RNAi, stems from the fact that
endogenous miRNAs usually basepair imperfectly with their tar-
gets and induce translational repression while perfect complemen-
tarity, which is common for dsRNA-induced silencing and artiﬁcial
siRNAs, induce the cleavage. However, miRNAs can mediate endo-
nucleolytic cleavage while siRNAs readily induce translational
repression [16,17]. The so-called off-targeting effect of siRNAs,
Fig. 2. Substrates of RNAi and their processing. (A) Four different mechanisms of dsRNA production result in structurally different dsRNAmolecules. (B) Small RNA (21–23 nt)
populations produced from two different types of dsRNA substrates. Both graphs show small RNAs from NGS mapped onto original sequences. In each case, mapping reads
were collapsed, so the Y-scale represents nucleotide counts mapped onto the (+) and () strand of the sequence. On the left are siRNAs produced by full-length Dicer from
viral dsRNA in infected ESCs (adapted from [80]). The right graph shows a small RNA (21–23 nt) proﬁle from ESC transfected with a plasmid expressing a long dsRNA hairpin
with long single-stranded overhangs (adapted from [52]). Distribution of mapped reads likely reﬂects differences in processing both substrates by full-length Dicer. (C) piRNA
clusters in mouse oocytes generate piRNAs and endo-siRNAs. Shown is distribution of unique reads of different lengths from NGS [38] mapped to four different piRNA clusters
annotated previously [39]. Indicated are small RNA lengths bound by different Argonaute proteins.
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tion of wide-ranging siRNA-mediated translational suppression of
imperfectly basepairing targets [18]. Mechanistical explanation
lies in structural features of the four mammalian Argonaute
(AGO) proteins, where only AGO2 retains the slicer activity and
cleaves perfectly basepaired cognate RNA (cleavage is sterically
prevented by mismatches in the center of the small RNA-cognate
RNA duplex) [17,19–21]. Taken together, the main mechanistical
distinction between RNAi and miRNA pathways in mammals is
reduced to the distinct substrates (long dsRNA and miRNA precur-
sors, respectively) processed into small RNAs by Dicer.
Mammalian RNAi (i.e. long dsRNA-induced RNAi) is somewhat
enigmatic, especially its presence and functions in somatic cells.
Although the popular RNAi approach demonstrates that artiﬁcially
produced siRNAs can induce robust RNAi-like effects, induction of
RNAi with long dsRNA does not work well in somatic cells [22].
One reason is that RNAi effects in somatic cells are readily masked
by a robust sequence-independent dsRNA response, which is com-
monly known as the interferon (IFN) response (reviewed in
[23,24]). However, the IFN response is not the sole reason for inef-
ﬁcient RNAi in somatic cells. We have previously shown that ubiq-
uitous long dsRNA expression in a transgenic mouse model does
not induce the IFN response, but robust RNAi effects was observed
only in the oocyte [25]. Next generation sequencing (NGS) of small
RNAs from tissues expressing dsRNA suggested poor processing of
dsRNA into siRNAs [25], which is consistent with minimal abun-
dance of putative endo-siRNAs in NGS data from somatic tissues.Correspondingly, functional analyses of Dicer showed that human
Dicer is efﬁciently processing miRNA precursors [26] but not long
perfect duplexes because of an auto-inhibitory function of the
N-terminal helicase domains [27].
However, a picture of a hidden and inefﬁcient RNAi in somatic
cells may be oversimpliﬁed because there are several reports of
long dsRNA-induced RNAi in transformed and primary somatic
cells [22,28–32]. It seems that, under poorly understood circum-
stances, RNAi may become functional even in somatic cells. A pos-
sible scenario leading to an efﬁcient RNAi response in somatic cells
could include abundant dsRNA present in the nucleus and high
expression of Dicer. Nuclear compartmentalization (Dicer can
localize and function in the nuclear compartment [33–35]) may
overcame the IFN response because nuclear dsRNA should not pro-
voke it while high levels of Dicer could partially compensate lower
activity and processivity of the full-length Dicer on long dsRNA
substrates.
3. Endogenous RNAi in mouse oocytes – a highly informative
exception of the rule
Mouse oocytes represent a unique case of mammalian RNAi. As
mentioned above, RNAi in mammals was ﬁrst reported from this
cell type [7,8]. Subsequently, it was shown that RNAi in mouse
oocytes can be induced with microinjected as well as expressed
dsRNA (reviewed in [36]). In mouse oocytes, dsRNA does not
induce sequence-independent effects because the IFN pathway is
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RNAs from all three mammalian RNA silencing pathways are pres-
ent in mouse oocytes [38,39]. However, only the RNAi pathway
seems to be functionally signiﬁcant in the oocyte because mutant
oocytes lacking piRNAs or miRNAs can support development to
the term [40–43]. In contrast to miRNAs and piRNAs, endo-siRNAs
seem to be essential for normal meiotic maturation because the
loss of Dicer and Ago2 results in a meiotic spindle defect. This
phenotype is most likely caused by the loss of endo-siRNAs and
not miRNAs as originally thought [44–46].
Remarkably, NGS of small RNAs in mouse oocytes revealed a
unique class of endo-siRNAs derived from processed pseudogenes
[38,39]. Transcriptomes of oocytes lacking Dicer and Ago2 are
similarly affected and genes matching pseudogene-derived endo-
siRNAs are enriched in the group of upregulated genes in both
knockouts [43–47]. In addition, putative endo-siRNA targets are
enriched in cell cycle regulators and genes involved in microtubule
organization and dynamics [38]. These ﬁndings suggest that regu-
lation of protein-coding genes by endo-siRNAs controls the equi-
librium of protein factors required for proper spindle formation,
chromosome segregation and meiosis progression in mouse
oocytes. As pseudogenes are a rapidly evolving source of dsRNA,
the role of RNAi in spindle formation during meiotic maturation
of oocytes may not be conserved across mammals.
Little evidence is available for potential role of endo-siRNAs in
the regulation of protein-coding mRNAs in other mammalian cell
types. Endo-siRNAs have also been proposed to contribute to the
self-renewal and proliferation of mouse ESCs, since the prolifera-
tion and differentiation defects observed in Dicer/ ESCs are more
dramatic than in Dgcr8/ ESCs [48–50]. In mouse hippocampus,
NGS revealed a set of potential endo-siRNAs generated from over-
lapping sense/antisense transcripts and from hairpin structures
within introns of protein-coding genes, many of which are
involved in control of synaptic plasticity [51].
Importantly, mouse oocytes express high levels of a unique
Dicer isoform (denoted DicerO), which is adapted for endo-siRNA
production (Fig. 1C). DicerO evolved as a consequence of a mouse
transcript (MT) retrotransposon insertion into the exon 6 of Dicer
gene (Fig. 1C), which resulted in expression of an N-terminally
truncated Dicer isoform in the oocyte [52]. Rodent-speciﬁc MT ret-
rotransposons are known to serve as oocyte-speciﬁc promoters
[53]. Their spreading through rodent genomes during evolution
represents a retrotransposon-mediated rewiring of maternal gene
expression. However, MT retrotransposon insertions do not only
mediate coordinated expression of maternal genes [53] but, as
exempliﬁed by DicerO, they can produce novel functions [52].
The MT retrotransposon insertion causing maternal expression of
DicerO isoform (Fig. 1C) is found only in the Muridae family (mice
and rats) but not in other rodents, such as squirrels or hamsters
[52]. Consistent with earlier studies [27], DicerO isoform shows
higher activity in vitro and its ectopic expression in cells increases
endo-siRNA levels [52]. Supporting the essential role of RNAi in
mouse oocytes, deletion of the DicerO-producing MT retrotranspo-
son results in the loss of DicerO expression in oocytes and meiotic
spindle defects, thus phenocopying oocyte-speciﬁc Dicer
knock-out [52]. The exact cause of the spindle defect is unknown,
but it is presumably caused by reduced levels of endo-siRNAs since
miRNA levels appear normal in oocytes lacking DicerO [52].
Taken together, mouse oocytes represent an outstanding case,
where Dicer was adapted for endo-siRNA production and RNAi
acquired an essential role associated with control of endogenous
gene expression. Expressing a shorter Dicer protein appears as a
simple way to activate RNAi in mammalian cells without affecting
miRNA biogenesis [52]. Despite that, mouse and rat oocytes are
only examples of natural Dicer isoforms lacking the N-terminal
helicase domain. Thus, the helicase domain has either someimportant role, or there must be some evolutionary pressure
against having ubiquitously highly active RNAi. For example,
virus-mediated suppression of RNAi and/or competition for dsRNA
between RNAi and the mammalian immune systemmight result in
less efﬁcient antiviral defense. This would constitute sufﬁcient
evolutionary force to keep RNAi activity at a low level that we
see in somatic cells today. In any case, one should be cautious
about generalizing data about RNA silencing coming from mouse
oocytes – it is simply not known whether siRNAs are essential
and miRNAs and piRNAs non-essential in oocytes of other
mammals.4. Retrotransposon suppression by RNAi
Initial mutant screens for RNAi components in C. elegans
revealed that RNAi is suppressing mobile elements [54,55]. NGS
and other experimental data suggest that RNAi-mediated silencing
of mobile elements also functions in mouse oocytes
[38,39,45,46,56,57]. Mobile elements are also suppressed by the
piRNA pathway, however, mammalian piRNAs are essential only
in the male but not female germline [40–42]. The piRNA and
endo-siRNA pathways likely cooperate in creating a complex
silencing network targeting mobile elements in the mammalian
germline. Long terminal repeat MT elements and SINE elements
are strongly upregulated in Dicer/ oocytes, while the levels of
IAP transposon seem to be elevated in the absence of Mili protein
but not in Dicer/ oocytes [39,45]. Still, many loci composed of
other types of TEs, e.g. LINE retrotransposons, give rise to both piR-
NAs and endo-siRNAs, suggesting again that the biogenesis of these
small RNAs is interdependent (Fig. 2C). Thus, it is possible that
highly active RNAi may functionally compensate piRNA knockout
phenotype in the mouse female germline. If so, piRNAs may have
a more pronounced role in oocytes of other mammalian species
lacking a functional equivalent of DicerO.
Importantly, the role of endogenous RNAi in retrotransposon
silencing in mice apparently extends from germ cells to embryos,
thus beyond the expression of DicerO. For example, SINE-derived
endo-siRNAs also increase in abundance in early embryo stages
and account for the majority of endo-siRNAs sequenced from
mouse ES cells (ESCs) [58]. Furthermore, RNAi contributes to con-
trol of LINE-1 retrotransposon in ESCs [59] and in HeLa cells [60].
LINE-1-derived siRNAs originate from convergent transcription at
the 50UTR [59,60]. However, the relationship between RNAi and
LINE-1 may be more complex. LINE-1 is a highly adapted and suc-
cessful mammalian retrotransposon [61,62], thus one would
expect that it evolved strategies to evade repression. Yet, LINE-1
still retains convergent transcription at its 50 end that should cause
RNAi-mediated reduction of LINE-1 transcript levels (or trimming
of the L1 transcript). This raises a question whether LINE-1 interac-
tion with RNAi could represent an adaptation of the LINE-1
retrotransposon rather than an effective way of LINE-1 suppression
by the host.5. RNAi as antiviral response in mammals
In invertebrates, RNAi functions as a form of innate immunity
(reviewed in [63,64]) because dsRNA is frequently produced during
viral infection: RNA viruses generate dsRNA during their replica-
tion cycle in host cells and DNA viruses often produce complemen-
tary sense and antisense transcripts. In C. elegans, endogenous viral
pathogens were unknown until recently [65,66]. Therefore, the
antiviral role of RNAi was studied by infecting with C. elegans
under laboratory conditions with viruses having a broad host range
such as the (+)ssRNA ﬂock house virus (FHV) [67] or the ()ssRNA
vesicular stomatitis virus (VSV) [68,69]. Infection with the
2554 P. Svoboda / FEBS Letters 588 (2014) 2550–2556recombinant VSV was augmented in strong RNAi mutants, which
also yielded higher viral titers. Similar results were obtained from
FHV infection of RNAi mutants [67]. The antiviral role of RNAi in
nematodes was later demonstrated with natural viral infections
of C. elegans and Caenorhabditis briggsae [65,66]. Similarly, an anti-
viral role of RNAi has been demonstrated in insects. It was shown
that FHV is an initiator and a target of RNA silencing in Drosophila
host cells [70]. To date, numerous studies provide ample evidence
that RNAi plays an essential role in antiviral response in insects
(reviewed in [71]). Taken together, the evidence for the antiviral
role of RNAi in invertebrates stems from the following concurrent
observations:
 Inhibition of RNA silencing results in increased viral replication.
 siRNAs derived from viral sequences are found in the infected
individual.
 Virus-encoded viral suppressors of RNA silencing (VSRs) are
found.
In mammals, data supporting the role of RNAi in antiviral
defense are contradictory and the antiviral role of RNAi has been
questioned (reviewed in [72]). Common arguments against the
antiviral function of mammalian RNAi are:
 Not all three above-mentioned observations occur concurrently.
 All three observations are made concurrently but not under
physiological conditions.
 There are alternative interpretations of any of the observations
because of a different setup of dsRNA-responding pathways in
mammals.
 RNAi encountering a virus is physiologically not important
because mammals have another effective antiviral response –
the IFN response.
While the IFN response makes RNAi redundant and obscured,
the existence of the IFN response is not a sufﬁcient argument to
dismiss the idea that RNAi is a functional secondary antiviral
defense engaged under speciﬁc conditions. At the same time, any
circumstantial evidence suggesting the role of RNAi in viral sup-
pression must be carefully examined. Since viruses co-evolve with
different hosts and explore all possible strategies to maintain and
increase their ﬁtness, it is not surprising that viral reproductive
strategies come into contact with mammalian RNA silencing path-
ways, particularly the miRNA pathway, which shares components
with the RNAi pathway. For example, Epstein–Barr virus (EBV)
and several other viruses encode their own miRNAs [73–75] or
take advantage of host cell miRNAs to enhance their replication
[73,76].
Generally, data support the idea that RNAi is not broadly
engaged in antiviral defense. For example, no siRNAs of viral origin
have been found in human cells infected with a wide range of
viruses [73,77]. Occasional observations, such as detection of a sin-
gle siRNA in HIV-1 infected cells [78], do not provide any conclu-
sive evidence that RNAi is processing viral dsRNA and suppresses
viruses under physiological conditions in vivo. Likewise, our exper-
iments with long dsRNA expression and RNAi induction in mouse
tissues [25] as well as properties of the full-length Dicer [27,52]
would argue against RNAi being an effective response to dsRNA
in somatic cells.
However, two remarkable reports show virus-derived endo-siR-
NAs in mammals [79,80]. One report used mouse ESCs, which con-
tain endo-siRNAs [58] and where dsRNA induces RNAi but not the
IFN response [81]. ESCs infected with encephalomyocarditis virus
(EMCV) yielded siRNAs generated from the dsRNA terminus in a
Dicer-dependent manner (Fig. 2B). This pattern is consistent with
Dicer’s preference for processing dsRNA from the end as well aswith low processivity of the full-length Dicer, which is expressed
in ESCs. However, EMCV accumulated less in ESCs lacking Dicer
than in normal ESCs, which is not consistent with the antiviral
effect of RNAi, but that could reﬂect pleiotropic effects the Dicer
deletion on ESCs [48,49,82,83]. Remarkably, ESC infection with
Nodamura Virus (NoV), a mosquito transmissible virus related to
FHV, yielded high amounts of endo-siRNAs only when a mutant
virus was used that lacked the dsRNA binding protein B2 (NovDB2)
[80], which has properties of Dicer-inhibiting VSR [84]. Taken
together, virus-infected ESCs suggest that the RNAi pathway will
function as an antiviral response in the absence of the IFN
response.
The second report of antiviral RNAi employed intraperitoneal
injection ofNoV into sucklingmice [79]. Authors also observed siRNA
accumulation (detectable by Northern blotting) and reduced viral
RNA accumulation upon infection with the NovDB2 mutant [79].
Although the route of infection with NoV was non-physiological
and it is unclear, which cell type was responsible for endo-siRNA
production, these data suggest that some cells in sucklingmice have
enough Dicer activity to generate robust siRNA levels from long
dsRNA.
Another argument for an interaction between viruses and RNAi
in mammals is the presence of VSRs in viruses infecting mammals.
Since viral genomes rapidly evolve, presence of a VSR should be
functionally signiﬁcant. The aforementioned B2 protein from Nod-
aviruses (e.g. NoV or FHV) is aVSR example. It is essential for viral
replication, inhibits Dicer function, and B2-deﬁcient FHV can be
rescued by artiﬁcial inhibition of RNAi response [70]. B2 protein
also enhances the accumulation of Nodaviral RNA in infectedmam-
malian cells [79,80,85,86]. Other potential VSR molecules have
been identiﬁed in viruses infecting vertebrates, such as Adenovirus
VA1 non-coding RNA [87], Inﬂuenza NS1 protein [88], Vaccinia
virus E3L protein [88], Ebola virus VP35 protein [89], Tas protein
in primate foamy virus [90], HIV-1 Tat protein [78], or sfRNA in
West Nile virus [91].
However, VSRs in viruses infecting mammals do not prove that
these viruses are targeted by RNAi in mammalian cells. Viruses
may have a broader range of hosts (or vectors), including, for
example, blood sucking insects. Thus, a virus can be targeted by
RNAi in one host and by a different defense mechanism in another
one. For example, the Dengue virus, whose life cycle takes place in
humans and mosquitoes, is targeted by RNAi in mosquitoes and it
likely evolved some adaptation to circumvent the response [92].
The sfRNA from West Nile virus, which is suppressing RNAi (and
miRNA) in mammalian cells [91], might be a similar case. Further-
more, the primary effect of a VSR may be aimed at another defense
mechanisms recognizing and responding to dsRNA and, as a
consequence, VSR effects on RNA silencing are observed.
Finally, VSRs in mammalian cells may target the miRNA path-
way. Since biogenesis and mechanism of action of mammalian
miRNAs overlaps with RNAi, it is possible that the role of a VSR
may be modiﬁcation of cellular gene expression by suppressing
the activity of miRNAs. Interestingly, recent data suggest a close
interplay between the miRNA pathway and the IFN response
[93]. In non-infected cells, miRNAs suppress IFN-stimulated genes
while infection results in suppression of the RISC activity and
increased expression of IFN-stimulated genes [93]. Similarly,
increased susceptibility of Ago1/3 double-null mice to Inﬂuenza A
does not seem to be linked with RNAi (no increased viral replica-
tion) but rather with (miRNA-dependent?) impaired ability of lung
cells to tolerate Inﬂuenza-induced inﬂammation [94]. Thus, further
research is needed to test all possible scenarios. Unfortunately,
since miRNA and RNAi use the same protein factors, distinguishing
between the two pathways is experimentally challenging. The
miRNA pathway can be selectively suppressed by blocking Dgcr8,
a speciﬁc co-factor for miRNA biogenesis [50]. As for RNAi, there
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option to suppress RNAi is blocking Ago2 or using cells expressing
a catalytically inactive Ago2 mutant [95].
Taken together, there is growing amount of evidence that mam-
malian small RNA pathways take a part in the antiviral response. It
is tempting to speculate that viral adaptations overcoming the IFN
response could provide selective pressure to maintain RNAi as an
occasional secondary line of antiviral defense despite the evolution
of the vertebrate immune system made RNAi rudimentary. Conse-
quently, RNAi may play a protective role in vivo in cells naturally
lacking an effective IFN response. However, without further
rigorous testing, this is just a plausible hypothesis.
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